Tumor Necrosis Factor Receptor Superfamily Member 9 Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9 INDUSTRY

2.1 Summary about Tumor Necrosis Factor Receptor Superfamily Member 9 Industry

2.2 Tumor Necrosis Factor Receptor Superfamily Member 9 Market Trends

2.2.1 Tumor Necrosis Factor Receptor Superfamily Member 9 Production & Consumption Trends

2.2.2 Tumor Necrosis Factor Receptor Superfamily Member 9 Demand Structure Trends

2.3 Tumor Necrosis Factor Receptor Superfamily Member 9 Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Ultra-41BBL

4.2.2 PRS-342

4.2.3 ISAS-01

4.2.4 EU-101

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Gastric Cancer

4.3.2 Bladder Cancer

4.3.3 Cervical Cancer

4.3.4 Lymphoma

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Ultra-41BBL

5.2.2 PRS-342

5.2.3 ISAS-01

5.2.4 EU-101

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Gastric Cancer

5.3.2 Bladder Cancer

5.3.3 Cervical Cancer

5.3.4 Lymphoma

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Ultra-41BBL

6.2.2 PRS-342

6.2.3 ISAS-01

6.2.4 EU-101

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Gastric Cancer

6.3.2 Bladder Cancer

6.3.3 Cervical Cancer

6.3.4 Lymphoma

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Ultra-41BBL

7.2.2 PRS-342

7.2.3 ISAS-01

7.2.4 EU-101

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Gastric Cancer

7.3.2 Bladder Cancer

7.3.3 Cervical Cancer

7.3.4 Lymphoma

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Ultra-41BBL

8.2.2 PRS-342

8.2.3 ISAS-01

8.2.4 EU-101

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Gastric Cancer

8.3.2 Bladder Cancer

8.3.3 Cervical Cancer

8.3.4 Lymphoma

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Ultra-41BBL

9.2.2 PRS-342

9.2.3 ISAS-01

9.2.4 EU-101

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Gastric Cancer

9.3.2 Bladder Cancer

9.3.3 Cervical Cancer

9.3.4 Lymphoma

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Agenus Inc

10.1.2 Alligator Bioscience AB

10.1.3 Apogenix GmbH

10.1.4 BioInvent International AB

10.1.5 Eli Lilly and Co

10.1.6 Juno Therapeutics Inc

10.1.7 MacroGenics Inc

10.1.8 Pfizer Inc

10.1.9 Pieris Pharmaceuticals Inc

10.2 Tumor Necrosis Factor Receptor Superfamily Member 9 Sales Date of Major Players (2017-2020e)

10.2.1 Agenus Inc

10.2.2 Alligator Bioscience AB

10.2.3 Apogenix GmbH

10.2.4 BioInvent International AB

10.2.5 Eli Lilly and Co

10.2.6 Juno Therapeutics Inc

10.2.7 MacroGenics Inc

10.2.8 Pfizer Inc

10.2.9 Pieris Pharmaceuticals Inc

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Tumor Necrosis Factor Receptor Superfamily Member 9 Product Type Overview

Table Tumor Necrosis Factor Receptor Superfamily Member 9 Product Type Market Share List

Table Tumor Necrosis Factor Receptor Superfamily Member 9 Product Type of Major Players

Table Brief Introduction of Agenus Inc

Table Brief Introduction of Alligator Bioscience AB

Table Brief Introduction of Apogenix GmbH

Table Brief Introduction of BioInvent International AB

Table Brief Introduction of Eli Lilly and Co

Table Brief Introduction of Juno Therapeutics Inc

Table Brief Introduction of MacroGenics Inc

Table Brief Introduction of Pfizer Inc

Table Brief Introduction of Pieris Pharmaceuticals Inc

Table Products & Services of Agenus Inc

Table Products & Services of Alligator Bioscience AB

Table Products & Services of Apogenix GmbH

Table Products & Services of BioInvent International AB

Table Products & Services of Eli Lilly and Co

Table Products & Services of Juno Therapeutics Inc

Table Products & Services of MacroGenics Inc

Table Products & Services of Pfizer Inc

Table Products & Services of Pieris Pharmaceuticals Inc

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (Million USD) by Region 2021f-2026f

Table Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Forecast (Million USD) Share by Demand 2021f-2026f